Author: Khan, Suliman; Tombuloglu, Huseyin; Hassanein, Sameh E.; Rehman, Surya; Bozkurt, Ayhan; Cevik, Emre; Abdel-Ghany, Shaimaa; Nabi, Ghulam; Ali, Ashaq; Sabit, Hussein
Title: Coronavirus diseases 2019: Current biological situation and potential therapeutic perspective Cord-id: ln6695lf Document date: 2020_8_5
ID: ln6695lf
Snippet: Coronavirus Disease 2019 (COVID-19) caused by a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) was first reported in Wuhan, China at the end of December 2019. SARS-CoV-2 is a highly pathogenic zoonotic virus and closely related to the Severe Acute Respiratory Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). The COVID-19 was declared as a global pandemic due to its high infectiousness, and worldwide morbidities and mortalities. The Chinese scientis
Document: Coronavirus Disease 2019 (COVID-19) caused by a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) was first reported in Wuhan, China at the end of December 2019. SARS-CoV-2 is a highly pathogenic zoonotic virus and closely related to the Severe Acute Respiratory Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV). The COVID-19 was declared as a global pandemic due to its high infectiousness, and worldwide morbidities and mortalities. The Chinese scientists at the start of the outbreak reported genome sequences, which made the characterization of glycoproteins and other structural proteins possible. Moreover, researchers across the world have widely focused on understanding basic biology, developing vaccines, and therapeutic drugs against the COVID-19. However, until now, no promising treatment options, as well as vaccines, are available. In this review, we have described SARS-CoV-2's genome, transmission, and pathogenicity. We also discussed novel potential therapeutic agents that can help to treat the COVID-19 patients.
Search related documents:
Co phrase search for related documents- acid amplification and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- acid amplification and acute respiratory distress syndrome: 1, 2
- acid amplification and acute severe pneumonia: 1
- acid amplification and low detection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- acid amplification and low detection limit: 1, 2
- acid amplification and low income: 1, 2, 3, 4
- actual number and acute ards respiratory distress syndrome: 1
- actual number and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- actual number and acute respiratory distress syndrome: 1
- actual number and acute severe pneumonia: 1
- actual number and low detection: 1
- actual number and low income: 1
- acute ards respiratory distress syndrome and low detection: 1, 2
- acute ards respiratory distress syndrome and low income: 1, 2, 3, 4, 5, 6, 7, 8
- acute ards respiratory distress syndrome and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- acute ards respiratory distress syndrome and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
- acute ards respiratory distress syndrome and lymphocytopenia presence: 1
- acute ards respiratory distress syndrome and lymphopenia eosinopenia: 1
- acute respiratory and additional specimen: 1
Co phrase search for related documents, hyperlinks ordered by date